tailieunhanh - POTENTIAL CONFLICT OF INTEREST IN THE PRODUCTION OF DRUG COMPENDIA

The scale and operation of the supply chain of biomass production is influenced by geographic conditions, availability and economics of feedstock supply and volumes of value added product. Energy balance and the environmental impact of the processes and products are essential considerations in selecting a sustainable option. The growth of bio based industry in developing countries will require greater investments for both large volume products (. biofuels) and high value added products, such as bio based specialty chemicals or consumer goods. The growth in large volume product markets can potentially facilitate—at lower cost—the adaptation and/or creation of the appropriate physical infrastructure elements as well as stimulating enhancements in human capital—both specialised and general—to support the bio economy. Markets for the higher value added products in industry and consumer sectors can benefit from the improved infrastructure, and will providing more varied and sophisticated development alternatives in different parts of the world, depending on the natural and human capital available and the comparative advantages in different regions. . | Technology Assessment Technology Assessment Program White Paper Potential Conflict of Interest in the Production of Drug Compendia Prepared for Agency for Healthcare Research and Quality 540 Gaither Road Rockville Maryland 20850 April 27 2009 1 White Paper Potential Conflict of Interest in the Production of Drug Compendia PROJECT ID CMPE1207 April 27 2009 Duke Evidence-based Practice Center Duke Center for Clinical Health Policy Research 2200 West Main Street Suite 220 Durham NC 27705 919 286-3399 Ross McKinney MD Amy P. Abernethy MD David B. Matchar MD Jane L. Wheeler MSPH This report is based on research conducted by the Duke Evidence-Based Practice Center under contract to the Agency for Healthcare Research and Quality AHRQ Rockville MD Contract No HHSA 290 2007 10066-1 . The findings and conclusions in this document are those of the author s who are responsible for its contents the findings and conclusions do not necessarily represent the views of AHRQ. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the . Department of Health and Human Services. The information in this report is intended to help health care decision-makers patients and clinicians health system leaders and policymakers make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information . in the context of available resources and circumstances presented by individual patients. This report may be used in whole or in part as the basis for development of clinical practice guidelines and other quality enhancement tools or as a basis for reimbursement and coverage policies. AHRQ or . Department of Health and Human Services .